BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 26803429)

  • 41. Persistent Nonalcoholic Fatty Liver Disease Increases Risk for Carotid Atherosclerosis.
    Sinn DH; Cho SJ; Gu S; Seong D; Kang D; Kim H; Yi BK; Paik SW; Guallar E; Cho J; Gwak GY
    Gastroenterology; 2016 Sep; 151(3):481-488.e1. PubMed ID: 27283259
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Modest alcohol consumption and carotid plaques or carotid artery stenosis in men with non-alcoholic fatty liver disease.
    Sinn DH; Gwak GY; Cho J; Son HJ; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
    Atherosclerosis; 2014 Jun; 234(2):270-5. PubMed ID: 24704629
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Carotid intima-media thickness and flow-mediated dilation in obese children with non-alcoholic fatty liver disease.
    Torun E; Aydın S; Gökçe S; Özgen İT; Donmez T; Cesur Y
    Turk J Gastroenterol; 2014 Dec; 25 Suppl 1():92-8. PubMed ID: 25910377
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Atherosclerotic disease in axial spondyloarthritis: increased frequency of carotid plaques.
    Rueda-Gotor J; Corrales A; Blanco R; Fuentevilla P; Portilla V; Expósito R; Mata C; Pina T; González-Juanatey C; Llorca J; González-Gay MA
    Clin Exp Rheumatol; 2015; 33(3):315-20. PubMed ID: 26005760
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Epicardial Adipose Tissue (EAT) Thickness Is Associated with Cardiovascular and Liver Damage in Nonalcoholic Fatty Liver Disease.
    Fracanzani AL; Pisano G; Consonni D; Tiraboschi S; Baragetti A; Bertelli C; Norata GD; Dongiovanni P; Valenti L; Grigore L; Tonella T; Catapano A; Fargion S
    PLoS One; 2016; 11(9):e0162473. PubMed ID: 27627804
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gender-based differences in the relationship between fatty liver disease and atherosclerosis.
    Kim HJ; Lim CW; Lee JH; Park HB; Suh Y; Cho YH; Choi TY; Hwang ES; Cho DK
    Cardiovasc J Afr; 2016 Sep/Oct 23; 27(5):281-286. PubMed ID: 26972662
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Subclinical atherosclerosis is associated with Epicardial Fat Thickness and hepatic steatosis in the general population.
    Baragetti A; Pisano G; Bertelli C; Garlaschelli K; Grigore L; Fracanzani AL; Fargion S; Norata GD; Catapano AL
    Nutr Metab Cardiovasc Dis; 2016 Feb; 26(2):141-53. PubMed ID: 26777475
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The relation between carotid intima media thickness and serum osteoprotegerin levels in nonalcoholic fatty liver disease.
    Ayaz T; Kirbas A; Durakoglugil T; Durakoglugil ME; Sahin SB; Sahin OZ; Kirvar A; Tasci F
    Metab Syndr Relat Disord; 2014 Jun; 12(5):283-9. PubMed ID: 24689950
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prehypertension is associated with increased carotid atherosclerotic plaque in the community population of Southern China.
    Hong H; Wang H; Liao H
    BMC Cardiovasc Disord; 2013 Mar; 13():20. PubMed ID: 23510396
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Plasma S100A8/A9 correlates with blood neutrophil counts, traditional risk factors, and cardiovascular disease in middle-aged healthy individuals.
    Cotoi OS; Dunér P; Ko N; Hedblad B; Nilsson J; Björkbacka H; Schiopu A
    Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):202-10. PubMed ID: 24202303
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Frequency of Nonalcoholic Fatty Liver Disease and Subclinical Atherosclerosis Among Young Mexican Americans.
    Gill C; Vatcheva KP; Pan JJ; Smulevitz B; McPherson DD; Fallon M; McCormick JB; Fisher-Hoch SP; Laing ST
    Am J Cardiol; 2017 Jun; 119(11):1717-1722. PubMed ID: 28395890
    [TBL] [Abstract][Full Text] [Related]  

  • 52. No evidence of association between subclinical thyroid disorders and common carotid intima medial thickness or atherosclerotic plaque.
    Delitala AP; Filigheddu F; Orrù M; AlGhatrif M; Steri M; Pilia MG; Scuteri A; Lobina M; Piras MG; Delitala G; Lakatta EG; Schlessinger D; Cucca F
    Nutr Metab Cardiovasc Dis; 2015 Dec; 25(12):1104-10. PubMed ID: 26615224
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Non-alcoholic fatty liver disease with and without metabolic syndrome: Different long-term outcomes.
    Käräjämäki AJ; Bloigu R; Kauma H; Kesäniemi YA; Koivurova OP; Perkiömäki J; Huikuri H; Ukkola O
    Metabolism; 2017 Jan; 66():55-63. PubMed ID: 27423871
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Carotid plaque and intima-media thickness and the incidence of ischemic events in patients with atherosclerotic vascular disease.
    Keo HH; Baumgartner I; Hirsch AT; Duval S; Steg PG; Pasquet B; Bhatt DL; Roether J;
    Vasc Med; 2011 Oct; 16(5):323-30. PubMed ID: 21908682
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Non-alcoholic steatohepatitis and progression of carotid atherosclerosis in patients with type 2 diabetes: a Korean cohort study.
    Lee HH; Cho Y; Choi YJ; Huh BW; Lee BW; Kang ES; Park SW; Cha BS; Lee EJ; Lee YH; Huh KB
    Cardiovasc Diabetol; 2020 Jun; 19(1):81. PubMed ID: 32534588
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Relationship between carotid intima-media thickness and non valvular atrial fibrillation type.
    Proietti M; Calvieri C; Malatino L; Signorelli S; Corazza GR; Perticone F; Vestri AR; Loffredo L; Davì G; Violi F; Basili S;
    Atherosclerosis; 2015 Feb; 238(2):350-5. PubMed ID: 25555267
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Non-alcoholic fatty liver disease and subclinical atherosclerosis: A comparison of metabolically- versus genetically-driven excess fat hepatic storage.
    Di Costanzo A; D'Erasmo L; Polimeni L; Baratta F; Coletta P; Di Martino M; Loffredo L; Perri L; Ceci F; Montali A; Girelli G; De Masi B; Angeloni A; Catalano C; Maranghi M; Del Ben M; Angelico F; Arca M
    Atherosclerosis; 2017 Feb; 257():232-239. PubMed ID: 28027788
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association of nonalcoholic fatty liver disease with cardiovascular risk factors in obese adolescents: the role of interdisciplinary therapy.
    Sanches PL; de Piano A; Campos RM; Carnier J; de Mello MT; Elias N; Fonseca FA; Masquio DC; da Silva PL; Corgosinho FC; Tock L; Oyama LM; Tufik S; Dâmaso AR
    J Clin Lipidol; 2014; 8(3):265-72. PubMed ID: 24793347
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nonalcoholic fatty liver disease and vascular disease: state-of-the-art.
    Fargion S; Porzio M; Fracanzani AL
    World J Gastroenterol; 2014 Oct; 20(37):13306-24. PubMed ID: 25309067
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The metabolic syndrome and progression of carotid atherosclerosis over 13 years. The Tromsø study.
    Herder M; Arntzen KA; Johnsen SH; Mathiesen EB
    Cardiovasc Diabetol; 2012 Jun; 11():77. PubMed ID: 22738646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.